Literature DB >> 23846337

GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle.

Jung Hwan Yoon1, Yoo Jin Choi, Won Suk Choi, Hassan Ashktorab, Duane T Smoot, Suk Woo Nam, Jung Young Lee, Won Sang Park.   

Abstract

PURPOSE: Gastrokine 1 (GKN1) functions to protect the gastric antral mucosa and promotes healing by facilitating restoration and proliferation after injury. GKN1 is downregulated in Helicobacter pylori-infected gastric epithelial cells and loss of GKN1 expression is closely associated with gastric carcinogenesis, but underlying mechanisms of the tumor-suppressing effects of GKN1 remain largely unknown. EXPERIMENTAL
DESIGN: AGS, MKN1, MKN28 gastric cancer cells and HFE-145 immortalized non-neoplastic gastric mucosal cells were transfected with GKN1 or shGKN1. We conducted molecular and functional studies of GKN1 and miR-185 and investigated the mechanisms of alteration. We also analyzed epigenetic alterations in 80 gastric cancer tissues.
RESULTS: Restoration of GKN1 protein suppressed gastric cancer cell growth by inducing endogenous miR-185 that directly targets epigenetic effectors DNMT1 and EZH2 in gastric cancer cells. In addition, ectopic expression of GKN1 upregulated Tip60 and downregulated HDAC1 in an miR-185-independent manner, thereby inducing cell-cycle arrest by regulating cell-cycle proteins in gastric cancer cells. Notably, GKN1 expression was inversely correlated with DNMT1 and EZH2 expression in a subset of 80 gastric cancer tissues and various gastric cancer cell lines. Interestingly, it was found that GKN1 exerted a synergistic anti-cancerous effect with 5-fluorouracil on tumor cell growth, which suggests a possible therapeutic intervention method for gastric cancer.
CONCLUSION: Our results show that GKN1 has an miR-185-dependent and -independent mechanism for chromatic and DNA epigenetic modification, thereby regulating the cell cycle. Thus, the loss of GKN1 function contributes to malignant transformation and proliferation of gastric epithelial cells in gastric carcinogenesis. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846337     DOI: 10.1158/1078-0432.CCR-12-3675

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  28 in total

1.  Gastrokine 1 protein is a potential theragnostic target for gastric cancer.

Authors:  Jung Hwan Yoon; In-Hye Ham; Olga Kim; Hassan Ashktorab; Duane T Smoot; Suk Woo Nam; Jung Young Lee; Hoon Hur; Won Sang Park
Journal:  Gastric Cancer       Date:  2018-04-27       Impact factor: 7.370

2.  Gastrokine 1 inhibits gastrin-induced cell proliferation.

Authors:  Olga Kim; Jung Hwan Yoon; Won Suk Choi; Hassan Ashktorab; Duane T Smoot; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Gastric Cancer       Date:  2015-03-10       Impact factor: 7.370

3.  The miR-185/PAK6 axis predicts therapy response and regulates survival of drug-resistant leukemic stem cells in CML.

Authors:  Hanyang Lin; Katharina Rothe; Min Chen; Andrew Wu; Artem Babaian; Ryan Yen; Jonathan Zeng; Jens Ruschmann; Oleh I Petriv; Kieran O'Neill; Tobias Maetzig; David J H F Knapp; Naoto Nakamichi; Ryan Brinkman; Inanc Birol; Donna L Forrest; Carl Hansen; R Keith Humphries; Connie J Eaves; Xiaoyan Jiang
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

Review 4.  Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Authors:  Diogo Libânio; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  World J Clin Oncol       Date:  2015-10-10

Review 5.  Regulation of protein stability of DNA methyltransferase 1 by post-translational modifications.

Authors:  Anthony Scott; Jing Song; Rob Ewing; Zhenghe Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-01-03       Impact factor: 3.848

6.  TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185.

Authors:  Feng Qiu; Jian-Ping Xiong; Jun Deng; Xiao-Jun Xiang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  miR-185 enhances the inhibition of proliferation and migration induced by ionizing radiation in melanoma.

Authors:  Jinpeng He; Ning Tian; Yanli Yang; Liangliang Jin; Xiu Feng; Junrui Hua; Sulan Lin; Bing Wang; He Li; Jufang Wang
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

8.  Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.

Authors:  Jung Hwan Yoon; Won Suk Choi; Olga Kim; Byung Joon Choi; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Gastric Cancer       Date:  2016-06-01       Impact factor: 7.370

9.  Polymorphisms in C-reactive protein and Glypican-5 are associated with lung cancer risk and Gartrokine-1 influences Cisplatin-based chemotherapy response in a Chinese Han population.

Authors:  Shuo Zhang; Asmitananda Thakur; Yiqian Liang; Ting Wang; Lei Gao; Tian Yang; Yang Li; Tingting Geng; Tianbo Jin; Tianjun Chen; Johnson J Liu; Mingwei Chen
Journal:  Dis Markers       Date:  2015-04-27       Impact factor: 3.434

Review 10.  Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.

Authors:  Mohammad Reza Karimzadeh; Peyman Pourdavoud; Naeim Ehtesham; Mohaddese Qadbeigi; Masood Movahedi Asl; Behrang Alani; Meysam Mosallaei; Bahram Pakzad
Journal:  Cancer Gene Ther       Date:  2020-08-10       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.